A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA.
Blood
; 143(12): 1112-1123, 2024 Mar 21.
Article
in En
| MEDLINE
| ID: mdl-37946262
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Thrombotic Microangiopathies
Limits:
Adult
/
Child
/
Humans
Language:
En
Journal:
Blood
Year:
2024
Type:
Article